Phibro Animal Health Corporation Research and Development Expense
Phibro Animal Health Corporation (PAHC) reported Research and Development Expense of $24.55 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-26
- Phibro Animal Health Corporation research and development expense for fiscal 2026 was $24.55M, a 3.48% increase from fiscal 2025.
- Phibro Animal Health Corporation research and development expense for fiscal 2025 was $23.73M, a 18.73% decline from fiscal 2024.
- Phibro Animal Health Corporation research and development expense for fiscal 2024 was $29.19M, a 19.67% increase from fiscal 2023.
- Phibro Animal Health Corporation research and development expense for fiscal 2023 was $24.39M, a 17.10% increase from fiscal 2022.
| Period end | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|
| 2026-06-30 | $24.55M 10-K · filed 2026-08-26 | |
| 2025-06-30 | $23.73M 10-K · filed 2026-08-26 | |
| 2024-06-30 | $29.19M 10-K · filed 2026-08-26 | |
| 2023-06-30 | $24.39M 10-K · filed 2025-08-27 | |
| 2022-06-30 | $20.83M 10-K · filed 2024-08-28 | |
| 2021-06-30 | $17.76M 10-K · filed 2023-08-30 | |
| 2020-06-30 | $13.74M 10-K · filed 2022-08-24 | |
| 2019-06-30 | $12.09M 10-K · filed 2021-08-25 | $12.08M 10-K · filed 2019-08-27 |
| 2018-06-30 | $10.00M 10-K · filed 2020-08-26 | |
| 2017-06-30 | $9.44M 10-K · filed 2019-08-27 | |
| 2016-06-30 | $11.03M 10-K · filed 2018-08-27 | |
| 2015-06-30 | $9.51M 10-K · filed 2017-08-30 | |
| 2014-06-30 | $8.21M 10-K · filed 2016-08-29 | |
| 2013-06-30 | $6.64M 10-K · filed 2015-09-10 | |
| 2012-06-30 | $7.19M 10-K · filed 2014-09-18 |